EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum

Megan Wiggins iD, Jeff Round iD, Erin Kirwin

International Journal of Technology Assessment in Health Care · 2025

DOI: 10.1017/s0266462325100172 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift International Journal of Technology Assessment in Health Care, 2025. Verfasst von Megan Wiggins und 2 weiteren Autor:innen. Beteiligte Einrichtung: https://ror.org/03e81x648Institute of Health Economics, Edmonton, AB, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cost-Benefit Analysis, Continuity of Patient Care, Models, Economic. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alberta Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this study is to develop a patient-level model for type 2 diabetes mellitus (T2DM) progression that can estimate the cost-effectiveness of T2DM interventions from prevention to management.

Methods

We developed an individual-level microsimulation model, the Institute of Health Economics Diabetes Model (IHE-DM), that simulates: (i) T2DM progression from normal glucose tolerance (NGT) to T2DM, (ii) the occurrence and timing of eight comorbidities and death, and (iii) the correlated progression of risk factors over time. We report model validation and use a case study to investigate the cost-effectiveness of a hypothetical T2DM prevention program.

Results

The internal validation indicated excellent performance with mean absolute differences between the predicted and observed values for all endpoints of less than 1 percent. External validation results were mixed. The model under-predicted cumulative T2DM incidence in the first 8 years, predicted well from years eight through eleven, and over-predicted from years twelve through fifteen. Our case study estimated an incremental net monetary benefit of CAD 2,701 (USD 2,289) (95% Uncertainty Interval: CAD 1,316 to 4,000 [USD 1,115 to 3,390]) over the 15-year time horizon.

Conclusions

Prominent T2DM models focus on patients with diagnosed T2DM whereas our model simulates progression from NGT to T2DM and incorporates important correlations in the progression of risk factors. These adaptations allow us to evaluate preventative interventions and better capture the long-term impacts, filling an important gap in the evidence base. Our model can be used to inform future funding decisions for T2DM interventions across the care continuum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cost-Benefit AnalysisContinuity of Patient CareModels, EconomicHumansDisease ProgressionMiddle AgedMaleFemaleRisk FactorsQuality-Adjusted Life YearsAgedTechnology Assessment, Biomedical

Stichwörter der Autor:innen

computer simulationcost-effectiveness analysisdiabetes mellitusmicrosimulationpreventive caretype 2

Autor:innen und Institutionen

  • https://ror.org/03e81x648Institute of Health Economics, Edmonton, AB, Canada.
  • Faculty of Medicine and Dentistry, https://ror.org/0160cpw27University of Alberta, Edmonton, AB, Canada.
  • Health Organisation, Policy, and Economics, School of Health Sciences, https://ror.org/027m9bs27University of Manchester, Manchester, UK.

ORCID-Profile: Megan Wiggins, Jeff Round

Förderung

  • Alberta Health Services

Zitieren

APA

Wiggins, M., Round, J., & Kirwin, E. (2025). Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum. International Journal of Technology Assessment in Health Care. https://doi.org/10.1017/s0266462325100172

Vancouver

Wiggins M, Round J, Kirwin E. Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum. International Journal of Technology Assessment in Health Care. 2025. doi:10.1017/s0266462325100172

BibTeX
@article{Wiggins2025,
  author = {Wiggins, Megan and Round, Jeff and Kirwin, Erin},
  title = {Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum},
  journal = {International Journal of Technology Assessment in Health Care},
  year = {2025},
  doi = {10.1017/s0266462325100172}
}
Kostenlos starten →